Abbot Financial Management’s Medtronic MDT Stock Holding History

Abbot Financial Management’s Portfolio MDT Stock Details MDT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$376K	Buy	4,336 +42	+1%	+$4.02K	0.16%	114
2025 Q4	$412K	Hold	4,294	–	–	0.17%	112
2025 Q3	$409K	Sell	4,294 -950	-18%	-$87.3K	0.17%	109
2025 Q2	$457K	Hold	5,244	–	–	0.21%	100
2025 Q1	$471K	Buy	5,244 +17	+0.3%	+$1.52K	0.24%	98
2024 Q4	$418K	Sell	5,227 -300	-5%	-$26K	0.21%	101
2024 Q3	$498K	Hold	5,527	–	–	0.25%	100
2024 Q2	$435K	Buy	5,527 +100	+2%	+$8.2K	0.23%	101
2024 Q1	$473K	Buy	+5,427	New	+$463K	0.26%	97

Other funds holding MDT

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Abbot Financial Management's MDT Position: Q1 2026 in Review

Abbot Financial Management increased its Medtronic (MDT) stake by 0.98% in Q1 2026, buying an estimated $4.02K and bringing the position to 4,336 shares worth $376K. The position accounts for 0.16% of the portfolio, ranked #114.

Abbot Financial Management first reported a position in MDT in Q1 2024 and has held it in 9 quarters since. The position peaked at $498K in Q3 2024. 2,229 funds tracked by Wall St. Rank hold MDT as of Q1 2026.

Abbot Financial Management held 4,336 shares of Medtronic worth $376K as of Q1 2026.
Abbot Financial Management bought 42 Medtronic shares in Q1 2026, an estimated $4.02K.
Medtronic made up 0.16% of Abbot Financial Management's portfolio in Q1 2026, its #114 holding.
Abbot Financial Management first reported a position in Medtronic in Q1 2024 and has held it in 9 quarters since.
Abbot Financial Management's Medtronic position peaked at $498K in Q3 2024.
2,229 funds tracked by Wall St. Rank held Medtronic as of Q1 2026.

Based on Abbot Financial Management's 13F filing for Q1 2026, filed 13 May 2026.